TACE-HAIC versus TACE as Initial Regional Therapy for Unresectable Huge Hepatocellular Carcinoma (>10 cm): A Propensity Score-Matched Study
Compared to TACE alone, TACE-HAIC therapy presented an acceptable safety profile, and offered improved local efficacy and prolonged survival benefits in patients with unresectable huge HCC (> 10 cm).
Authors
- Ming Zhao (ORCID: https://orcid.org/0000-0002-1025-8895)
- Lin Zheng (ORCID: https://orcid.org/0000-0002-4972-1015)
- Chong Liu (ORCID: https://orcid.org/0000-0002-9451-9676)
- Jincheng Xiao
- Jing Li (ORCID: https://orcid.org/0000-0002-2100-4284)
Institutions
- Sun Yat-sen University (CN)
- Zhengzhou University (CN)
- Henan Cancer Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/jhc.s537950
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32